‡ In these countries please contact our distributor

Independent Non-Executive Director - Katarzyna Mazur-Hofsaess

Appointed on 1 November 2020.

Career and Experience

Katarzyna qualified as a medical doctor (Ph.D.) from the Medical University of Gdańsk, Poland in 1987 and completed an Executive MBA at the University of Minnesota, US, in 2002. Katarzyna commenced her corporate career in 1998 at Roche where she progressed into roles of increasing management responsibility to become the Business Unit Manager of their Polish pharmaceutical division. Her rising professional profile accompanied by her strong academic background led to her appointment as General Manager for Poland of Allergy Therapeutics in 1999. Katarzyna was recruited by Abbott Laboratories in 2001 where she successfully managed their diabetes care division in Poland. Over the next nine years, her career accelerated rapidly at Abbott Laboratories, which saw her progression to Divisional Vice President for Europe. In 2010, Katarzyna continued her career at Zimmer as President of their EMEA region. Following her appointment as an executive committee member, her responsibilities increased significantly, particularly as the business grew following the Biomet acquisition. Katarzyna supported the operations of the Zimmer-Biomet portfolio that covered a variety of functional areas including sales, marketing, distribution, logistics, and clinical support. Since 2018, Katarzyna has served as CEO for the €2.7 billion EMEA business of Fresenius Medical Care AG & Co. KGaA, the German-listed renal care company.

Other current appointments

  • Chief Executive Officer, EMEA, at Fresenius Medical Care AG & Co. KGaA
  • NED at Vifor Fresenius Medical Care Renal Pharma Ltd.

Skills and Competencies

 Katarzyna demonstrates a true passion for customer focus and maintains an impressive track record in senior leadership within the MedTech industry. She is a qualified medical doctor (Ph.D.) and has a wealth of experience in medical devices and orthopaedic sectors. Her CEO experience of a global company and valuable industry knowledge will help drive innovation and ensure the continued development of Smith+Nephew across different geographic markets.